More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Appendix 4C - quarterly

Jan 25, 2017 at 5:54 AM EST · Issued by Cynata Therapeutics Limited

Filed with ASX · Jan 25, 2017 at 5:54 AM EST

On 6ix: 6ix.com/news/appendix-4c-quarterly-225

Cynata Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cynata Therapeutics Limited on 6ix

Earlier from Cynata Therapeutics

  • Cynata Successfully Completes Capital RaisingJan 22, 2017
  • Cynata & FUJIFILM Sign Strategic Partnership AgreementJan 18, 2017
  • Cynatas Clinical Study Approved in AustrraliaDec 15, 2016
  • Cynata Receives NHS HRA Approval for Clinical StudyDec 12, 2016
  • Cynata Files Further Patent ApplicationNov 28, 2016

Later from Cynata Therapeutics

  • Positive Preliminary Data from Preclinical HeartAttack StudyFeb 1, 2017
  • Final GvHD Preclinical Report Confirms Treatment BenefitFeb 5, 2017
  • CYP Advances Development of Cymerus for Treatment of AsthmaMar 1, 2017
  • Cynata Partner apceth GmbH & Co Completes Cymerus EvaluationMar 30, 2017
  • CYP in Collaboration on Acute Respiratory Distress SyndromeApr 10, 2017
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer